Mireia Camós

6PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 09, 2025
surviBALL: exploring lncRNA expression at diagnosis for 5-year EFS risk stratification in pediatric B-ALL-a proof of concept.

Unai Illarregi, Nerea Bilbao-Aldaiturriaga, Angela Gutierrez-Camino

|Mar 30, 2025
RNA-sequencing: A reliable tool to unveil transcriptional landscape of paediatric B-other acute lymphoblastic leukaemia.

Clara Vicente-Garcés, Guerau Fernández, Elena Esperanza-Cebollada

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Oct 28, 2024
Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children.

Alexandre Theron, Anna Alonso-Saladrigues, Jose-Luis Dapena

|Mar 23, 2023
A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia.

Elena Esperanza-Cebollada, Soledad Gómez-González, Sara Perez-Jaume

|Feb 03, 2018
A 4-gene expression prognostic signature might guide post-remission therapy in patients with intermediate-risk cytogenetic acute myeloid leukemia.

Montserrat Torrebadell, Marina Díaz-Beyá, Susana G Kalko

Pageof 1

Frequent Collaborators

3 joint publications

Montserrat Torrebadell

3 joint publications

Susana Rives

3 joint publications

Elena Esperanza-Cebollada

2 joint publications

Mercè Richarte-Franqués